Psychological Intervention and Schizophrenia
There are perhaps two main prongs to the development of Cognitive Behavioural Therapy as an intervention for schizophrenia, the first being based upon the sizable research that centre on family interventions, which have been successful in reducing patient relapse in schizophrenic families (Pilling et al., 2002). Family interventions are important to consider as they became established treatments during a phase where drug treatments were the main focus of attention in this field and so opened the area of non biological treatment for schizophrenia. And as I will touch upon later drug therapies are frequently used to reduce psychotic symptoms and relapse but these treatments rarely provide the answer, with as many as 50% of patients suffering from persistent psychotic symptoms when adhering to pharmacological treatments (Dickerson, 2000).
The other aspect that has seen CBT be considered as a treatment for schizophrenia is that it has been effective in treating a range of non-psychotic disorders both mild and more serious (e.g., Hawton, Salkovskis, Kirk, & Clark, 1989; Clark & Fairburn, 1997). The range of effective CB therapies stem from early studies where depression and anxiety disorders were the subject of interest (Beck et al., 1979; Barlow, 1988) to more serious psychotic disorders, such as bipolar disorder (Basco, Rush, 1995; Perry et al, 1999) and personality disorders (Beck et al, 1990).
While the success of family intervention, a non drug related therapy, and CBT’s success in treating various disorders provide evidence for the potential of CBT in treating schizophrenia they have been developed amid a backdrop in which drug therapy has been extensively explored, but has failed to produce a whole solution to the complexities exhibited by schizophrenia sufferers. It is likely then that as an intervention for schizophrenia CBT will provide a part solution rather than an all-encompassing answer. Detailed study of patients’ experiences has led to a greater understanding of the stress suffered by patients who go on to develop coping mechanisms, which can be treated using CBT, to deal with the symptoms of their illness (Mcnally, Goldberg, 1997). The fact then that there are so many aspects to this disease means that it would be impossible to provide a comprehensive review in this paper but I will discuss...
... middle of paper ...
..., Tarrier, N., Morriss, R., McCarthy, E., & Limb, K. (1999). A randomised controlled trial of teaching bipolar disorder patients to identify early symptoms of relapse and obtain early treatment. British Medical Journal, 318, 149–153.
Pilling, S., Bebbington, P., Kuipers, E., Garety, P., Geddes, J., Orbach, G. et al. (2002). Psychological treatments in schizophrenia: I. Meta-analysis of family interventions and cognitive behaviour therapy. Psychological Medicine, 32, 763–782.
Sensky T., Turkington D., Kingdon D., Scott J. L., Scott J., Siddle R., O'Carroll M. & Barnes T. (2000). A randomised controlled trial of cognitive-behavioural therapy for persistent symptoms in schizophrenia resistant to medication. Archives of General Psychiatry, 57: 165-172
Watts FN, Powell GE, Austin SV. 1973. The modification of abnormal beliefs. British Journal of Medical Psychology 46: 359–363.
Wiersma D., Jenner J. A., van de Willige G., Spakman M., Nienhuis F. J. (2001) Cognitive behaviour therapy with coping training for persistent auditory hallucinations in schizophrenia: a naturalistic follow-up study of the durability of effects. Acta Psychiatrica Scandinavica. 103 (5): 393-399
5). While Schizophrenia has been most commonly treated with the use of anti-psychotic medications for decades, cognitive therapy provides an alternative and cognitive psychologist would undoubtedly disagree with Elizabeth’s mother’s decision to medicate her. The way a cognitive psychologist would treat Elizabeth is by the use of therapy and encouraging her to talk about her behaviors and problems as they do not believe that Schizophrenia “is a biological illness that one either has or does not have” (Freeman, 2014, para. 7) and instead the symptoms such as hallucinations or delusions simply represent the patient’s thoughts and feelings (Freeman, 2014). For example, “an individual troubled by hearing voices will be helped to understand what’s triggering these voices, and to develop a more confident, empowering relationship with them” (Freeman, 2014, para.
Classical antipsychotic treatments are commonly used to treat schizophrenic patients with major positive symptoms of schizophrenia, such as Thorazine, Haldol, and Stelazine (Gleitman et al., 2011). Antipsychotic treatments are usually administered with a variety of psychosocial treatments including social skills training, vocational rehabilitation, supported employment, family therapy, or individual therapy (Barlow & Durand, 2014). This is to reduce relapse and help the patient improve their skills in deficits and comply in consuming the
Lehman, A. F., Lieberman, J. A., & Dixon, L. B. (2004) Practice guideline for the treatment of patients with schizophrenia, . American Journal of Psychiatry, 161 (2) 1 -56.
-Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005. Web.
Testing animals is used to develop medical treatments, determine the toxicity of medicinal drugs, check the safety of products intended for human use, and other biomedical, commercial, and healthcare roles. The earliest recordings of animal studies date back to Aristotle, who discovered the anatomical differences among animals by analyzing them (Introduction). Advocates of animal testing say that it has enabled the growth of numerous medical advancements, tests to see if new products are save for mankind, acquisition of new scientific knowledge, and because it is accurate (B). Opponents of animal testing say that it is cruel and inhumane to try out on animals, many animals die from the animal testing, it’s unethical, animals don’t have a say in it, the accuracy is in question because they are testing animals and not humans, and the toll of animal testing is high (B). Through the pros and cons of everything, it is bad to test animals because animals are very different from human beings and thus make poor test subjects and are unreliable, the cost and upkeep of it is expensive, and because there are alternatives to animal testi...
Animal testing is a largely debated and controversial issue. It was first introduced in the United States in the 1920s (Goldberg 85). Since then, there have been many advances in the field of medicine and science. These advances are due largely to the fact that animals are used in experiments and research. Animal testing has given doctors some of their most successful accomplishments. Also, they help researchers discover how to improve long known theories about the human mind and body. Over 40 Nobel Prizes have been given to researchers “whose achievements depended, at least in part, on using laboratory animals” (Trull 64). These animal experiments have helped humans live a better life. Animal testing benefits doctors...
Valmaggia LR, van der Gaag M, Tarrier N, Pijnenborg M, Slooff CJ. (2005) Cognitive–behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication The British Journal of Psychiatry (2005) 186: 324-330
Addington, J., Piskulic, D., & Marshall, C. (n.d). Psychosocial Treatments for Schizophrenia. Current Directions In Psychological Science, 19(4), 260-263.
...as, Lawrence Yusupoff, Eilis McCarthy, Caroline Kinney, and Anja Wittkowski. "Some Reasons Why Patients Suffering From Chronic Schizophrenia Fail to Continue in Psychological Treatment." Behavioral and Cognitive Psychotherapy 26 (1998): 177-81. Print.
Turkington, D & Dudley, R 2006, ‘Cognitive-behavioral therapy for schizophrenia: A review,’ Focus, vol. 4, pp. 223-233.
“No, I 'm more excited than anything but its going to be different not being home every night!” I answered.
(Man/Woman): Today we are going to talk about sleep and memory. The brain makes short-term memories, or memories that last a very short time, all of the time. However, long-term memories, or memories that last a very long time, are made when we sleep. Therefore, things you study before you sleep, can become long-term memories easier. It is very good for students to study just before they sleep. (67 words)
Schizophrenia is a devastating and costly mental disorder that affects 1% of population worldwide. Patients manifest clusters of positive, negative and cognitive symptoms in early twenties and are often left with life-long severe mental disability and social stigma. Cognitive deficits in patients with schizophrenia are considered core symptoms of this disorder, and can manifest at the initial stage (Elvevåg and Goldberg, 2000). Atypical antipsychotics ameliorate positive symptoms but may only modestly improve cognitive symptoms (Richelson, 2010). In addition to this, some of the typical antipsychotics are even have deteriorative effects on cognitive symptoms (Heaton and Crowley 1981). To find the appropriate treatments for cognitive deficits of schizophrenia, it is important to know the underlying pathophysiology.
For many years, animal testing has been the main solution to test household products, food, chemicals, and pharmaceuticals. The term “animal testing” refers to the procedure performed on certain animals to determine if a certain product is safe. Most of these procedures done on the animal can cause a great amount of physical pain, and distress. Most animals die shortly after the experiment because so much pain was inflicted on their body. After the testing is done, the animals are left to suffer in cages. The different types of experiments performed on the animals are outrageous. There is even an alternative to animal testing, but scientist refuse to use it, and some people wonder if animals are even needed for medical research.
BIBLIOGRAPHY Arasse, Daniel. Complete Guide to Mental Health. Allen Lane Press,New York, 1989. Gingerich, Susan. Coping With Schizophrenia. New Harbinger Publications, Inc. Oakland, 1994. Kass, Stephen. Schizophrenia: The Facts. Oxford University Press. New York, 1997. Muesen, Kim. “Schizophrenia”. Microsoft Encarta Encyclopedia. Microsoft Corporation, 1998. Young, Patrick. The Encyclopedia od Health, Psychological Disorders and Their Treatment. Herrington Publications. New York, 1991.